NCT02251561

Brief Summary

The purpose of this study is to compare an investigational contact lens care product (FID 109182) to a commercially available contact lens product (Opti-Free Plus®) for corneal staining when used with Acuvue® Oasys® contact lenses. The contact lenses will be pre-soaked in the products for 24-48 hours prior to a 2-hour contralateral wear period.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
36

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Nov 2013

Shorter than P25 for not_applicable

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 1, 2013

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2014

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2014

Completed
5 months until next milestone

First Submitted

Initial submission to the registry

September 25, 2014

Completed
4 days until next milestone

First Posted

Study publicly available on registry

September 29, 2014

Completed
8 months until next milestone

Results Posted

Study results publicly available

June 10, 2015

Completed
Last Updated

June 10, 2015

Status Verified

June 1, 2015

Enrollment Period

6 months

First QC Date

September 25, 2014

Results QC Date

May 20, 2015

Last Update Submit

June 3, 2015

Conditions

Keywords

contact lensescontact lens solutioncorneal stainingfluorescein

Outcome Measures

Primary Outcomes (1)

  • Proportion of Participants Scoring ≥ 2 for Corneal Staining Density With Fluorescein

    The contact lens was removed, the cornea was stained with fluorescein (ophthalmic dye), and pictures of the corneal surface were taken. Corneal staining density was evaluated for each eye individually against representative pictures and scored on a 0-3 scale (0=No staining; 1=Staining with low density; 2=Staining with moderate density; 3=Staining with severe density). Proportion of participants is reported as a percentage.

    Day 1, after 2 hours of wear

Secondary Outcomes (1)

  • Proportion of Participants Scoring ≥ 2 for Corneal Staining Area With Fluorescein

    Day 1, after 2 hours of wear

Study Arms (2)

FID 109182

EXPERIMENTAL

Senofilcon A contact lens pre-soaked in FID 109182 worn in the right or left eye as randomized for 2 hours

Device: FID 109182Device: Senofilcon A contact lens

Opti-Free Plus

ACTIVE COMPARATOR

Senofilcon A contact lens pre-soaked in Opti-Free Plus worn in the fellow eye for 2 hours

Device: Opti-Free PlusDevice: Senofilcon A contact lens

Interventions

Investigational multipurpose contact lens cleaning and disinfecting solution

Also known as: Opti-Free III
FID 109182

Commercially available multipurpose contact lens cleaning and disinfecting solution

Also known as: Opti-Free Plus®
Opti-Free Plus

Commercially available silicone hydrogel contact lens

Also known as: Acuvue® Oasys®
FID 109182Opti-Free Plus

Eligibility Criteria

Age20 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Soft contact lenses habitual wearer, both eyes.
  • Voluntarily sign Informed Consent.

You may not qualify if:

  • Unable to tolerate the ingredients in Opti-Free® and similar contact lens care products.
  • Potential use of eye drops during the study, including over-the-counter products, except for artificial tear eye drops.
  • Eye infection, blepharitis, iris inflammation, or severe eye inflammation.
  • Corneal staining greater than Grade 1 at baseline.
  • Pregnant, lactating, or intend to become pregnant during study period.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Results Point of Contact

Title
Director, Clinical & Regulatory Affairs, Division of Medical Affairs
Organization
Alcon Japan, Ltd.

Study Officials

  • Tsunemitsu Senta

    Alcon Japan, Ltd.

    STUDY DIRECTOR

Publication Agreements

PI is Sponsor Employee
No
Restriction Type
OTHER
Restrictive Agreement
Yes

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Intervention Model
SINGLE GROUP
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 25, 2014

First Posted

September 29, 2014

Study Start

November 1, 2013

Primary Completion

May 1, 2014

Study Completion

May 1, 2014

Last Updated

June 10, 2015

Results First Posted

June 10, 2015

Record last verified: 2015-06